Menu
Transforma la atención médica con nosotros. Líderes en medicina nuclear con cyclotron y ultrasonido. Innovación y excelencia para un futuro saludable en Chile.
Nucleotron Molecular Imaging & Technology, LLC (Nucleotron MIT), together with IONETIX Corporation, are pleased to make this offer for a comprehensive turnkey solution to establish a cyclotron, radiochemistry, clinical and research PET program.
Based on our 19 years of experience and expertise, we are pleased to introduce you our personalized solutions developed for creating a latest generation Radio-pharmacy Center.
The patented superconducting technology represents the new standard for radio- pharmaceutical production and assures your long-term investment, while enabling very fast start-up compared to conventional cyclotron solutions. We also want to assure you that our partnership will provide comprehensive, real-world clinical and research training, covering not only radiopharmaceutical production, but PET/CT protocol development, imaging, and interpretation experience at one of our related sites in the USA.
· IONETIX has developed the world’s first compact superconducting cyclotron. Founded in 2009 from the technology born after 15 years of research and development at world-class University MIT (Massachusetts Institute for Technologists, USA) Plasma Science and Fusion Center, The ION- 12SC system is pioneering radio-pharmaceutical end-to-end solution provides fast and precise production of F-18, N-13 Ammonia and Ga-68, while being small enough to be installed in a very compact space.
· Nucleotron MIT is a U.S. company, based in Florida, and founded in 2006 by Nuclear Engineers, Radiochemists, Medical Physicists, and Nuclear Medicine Physicians. We are leaders in Innovation, technology, preclinical and clinical research using novel Radiopharmaceuticals. Nucleotron MIT operates a network of PET/CT and cyclotron centers in Florida with plans for national expansion.
-Ionetix has developed a first-generation cyclotron, the first of its kind, representing a new order of magnitude improvement over conventional cyclotron technology.
The ION-12 SC is a 12 MeV, 10 μA superconducting cyclotron that uses a patent protected design based on superconducting magnets to reduce its size.
You can provide N-13 ammonia PET radiopharmaceutical consistently and reliably, as well as F-18 at the point of care, to meet the most demanding workload.
This technology will usher in an era in which PET radioisotopes can be produced on demand, simplifying the logistics flow of high-volume laboratories.
Considering the limited availability of these radiopharmaceuticals so far due to their short lives and the size, expense, and complexity of conventional cyclotrons, this is a major step forward in nuclear imaging diagnostic capabilities
Short-lived PET radioisotopes have had limited adoption due to the size, weight, and cost of conventional cyclotrons
The ION-12SC is based on proprietary superconducting cyclotron technology
• Significantly smaller size, lighter weight and lower cost than conventional cyclotrons
• Lower energy consumption and requires less radiation shielding
• Significantly shorter installation time and simpler operations
• The compact size / weight allows for hospital or clinic placement without special infrastructure.
• Production on Demand
